A first healthy volunteer has been enrolled in a Phase 1 trial and given a first dose of PrimeC, an investigational combination therapy for people with amyotrophic lateral sclerosis (ALS), the treatment’s developer, NeuroSense Therapeutics, announced. The open-label Phase 1 trial (NCT05232461) is a pharmacokinetic study, or one that evaluates how a treatment moves into, through, and out of […]

Prescription digital therapeutics providers (PDTs) have been pushing for recognition and acceptance in the health care sector for years. That effort got a major boost thanks to a seemingly minor administrative move from the federal government. In February, the Centers for Medicare & Medicaid Services (CMS) announced the creation of a new reimbursement code for […]

Chemotherapy and radiation therapies, long the bane of cancer patients, are being replaced or augmented with a new generation of radiopharmaceutical therapies that offer greater specificity and, therefore, fewer side effects. Philip Kantoff, CEO of Convergent Therapeutics, spoke to BioSpace before the American Association for Cancer Research (AACR) Annual Meeting on April 8-13 about CONV01-α. This is his […]